Drug intelligence / Profile preview

AdStart

Development stage: Unknown
Lead developer: ADBiotech
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

AdStart is a veterinary feed additive developed and marketed by ADBiotech, a South Korean biotechnology company specializing in egg-derived antibody (IgY) technology. AdStart is utilized in the livestock and aquaculture industries to promote animal health and prevent infectious diseases through passive immunization. By incorporating specific IgY antibodies into animal feed, the product helps neutralize pathogens in the gastrointestinal tract, thereby improving growth rates and reducing mortality in young animals such as calves, piglets, and farmed fish. It is part of a broader product line that includes other IgY-based supplements like IgY Drink C and IgY Drink Plus.

Brand names: AdStart애드스타트
Other names: 애드스타트

Beyond the preview

Go deeper on AdStart.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AdStart.

Explore the full profile